Market Newsdesk

LOS ANGELES, April 07, 2021 (GLOBE NEWSWIRE) — IRIS.TV, the leading video data platform, today announced the completion of a $18 million Series B funding round. Intel Capital, a division of Intel Corporation, led the round, with participation from investors including WISE Ventures, Quest Venture Partners, and Mirae Asset Venture Investment. The round also included prominent leaders in the space including Mike Baker, founder, CEO of dataxu (acquired by Roku in 2019), Mike Shehan, founder, CEO of video advertising platform SpotX (merging with Magnite in 2021), and Ari Paparo, CEO of ad tech innovator Beeswax (acquired by Comcast in 2020). The new round of investment will enable IRIS.TV to accelerate the growth of its video data platform, and API tools that enable video-level data targeting for Connected TV (CTV) and online video.

IRIS.TV was founded in 2013 by CEO Field Garthwaite and COO Richie Hyden to help major media companies harness the power of machine learning and video data connectivity to build profitable video businesses online. For an industry struggling to untangle the challenges of brand safety, fraud, and transparency in the CTV and online video marketplaces, IRIS.TV provides video-level transparency by connecting media companies’ video data with trusted third-party verification partners and the advertising and marketing technology ecosystem in a privacy-first, neutral, and secure way. This allows for every video play, in every format and device, to be relevant, brand-safe, and measurable.

IRIS.TV’s video data platform simplifies the complexity and fragmentation of the video and CTV ecosystem by connecting and unifying video data from any source to power better consumer experiences and drive business outcomes. Before IRIS.TV, contextual and brand-safety data for videos was only available by analyzing the text on a web page–and was an impossibility for connected TV. Now, for the first time, marketers can “think inside the video” with the transparency to confidently buy CTV and premium video inventory based on video-level contextual and brand-safety analysis of the specific topical nature of every video. There are thousands of “IRIS-enabled” premium publishers around the world with over 300 billion annual views and growing rapidly.

“IRIS.TV is uniquely positioned to capitalize on the tremendous growth in online video viewership and the attendant need for brands and publishers to better monetize existing content in a Connected TV world,” said Marcelino Ford-Livene, Managing Director, Intel Capital. “We are excited to be involved in IRIS.TV’s rapid growth in this emerging sector.”

Connected TV experienced tremendous growth in 2020, as Leichtman Research Group estimated that four in five U.S. homes have at least one CTV device. While viewers flocked to CTV as a result of COVID-19 stay-at-home orders, advertisers were reticent to increase spending proportionally due to a lack of transparency and no data filters. IRIS.TV’s video data platform connects all video data at the video-level from any source to the digital advertising ecosystem for analysis, segmentation, and activation by third parties such as Oracle Data Cloud, Comscore, GumGum, ZEFR, Advanced Contextual, and Silverbullet.

“We are thrilled to have Intel Capital as an investor, which will allow us to build the data infrastructure for the future of video and Connected TV,” said Field Garthwaite, CEO of IRIS.TV. “This investment will allow IRIS.TV to expand operations with a focus on three key areas of growth. First, we’re looking to continue hiring world class talent and developers. Second, we will be expanding our strategic partnerships across the ecosystem to enable marketers and advertisers to utilize video-level data to achieve their business goals. Lastly, we will be investing in new API’s and features to provide the tools publishers, ad platforms, and marketers need to successfully invest in the fast-growing Connected TV space.”

ABOUT IRIS.TV

IRIS.TV’s mission is to connect and unify video data to power better consumer experiences and business outcomes. IRIS.TV’s video data platform is a neutral, privacy-first, cookieless solution that provides publishers, broadcasters and Connected TV apps with secure onboarding and activation of third-party data segments. Since 2013, IRIS.TV has enabled our partners to build scalable solutions on top of our platform including video-level contextual and brand-safe ad targeting, third-party verification, personalized video recommendations, and measurement & analytics solutions. For more information, visit www.iris.tv.

ABOUT INTEL CAPITAL

Intel Capital invests in innovative startups targeting cloud and AI infrastructure, 5G, edge, autonomy, cybersecurity, client and gaming, enterprise applications, silicon design and manufacturing, and a wide range of other disruptive technologies. Since 1991, Intel Capital has invested US$13.3 billion in more than 1,595 companies worldwide, and 707 portfolio companies have gone public or participated in a merger. For more information on what makes Intel Capital one of the world’s most powerful venture capital firms, visit www.intelcapital.com or follow @Intelcapital.

Contact:

Alexandra Levy
650-996-5758
[email protected] 

Columbus, Ohio & Staten Island, New York, April 07, 2021 (GLOBE NEWSWIRE) — The Jordre Well, LLC (“The Jordre Well”, the “Company”), a hemp and cannabidiol (“CBD”) beverage company that is 49% owned by Coffee Holding Co., Inc. (NASDAQ: JVA), a leading integrated wholesale coffee roaster and dealer in the United States, is pleased to announce that it will participate in the upcoming CBD Expo Midwest 2021, to be held on April 9, 2021 and April 10, 2021 at the Indianapolis Marriott East in Indianapolis, Indiana. 

The Jordre Well’s Founder and CEO, Ian James, will present in the panel titled “Cannabinoids in Food and Beverage: Market Trends, Innovation, and What the Future Holds,” from 10:15 am – 11:00 AM on Friday, April 9th in Panel Room B. 

Powered by Mace Media Group, CBD Expo Midwest 2021 is the largest regional CBD event platform to broadcast products to the community and share CBD knowledge with the industry. Open to the public, everyone is invited, from entrepreneurs and professionals to curious consumers, this event is expected to feature more than 100  verified storefront buyers.

“The Jordre Well and its partners at Coffee Holding Company will share our pilot run of CBD-infused Café Caribe and Harmony Bay coffee products with potential B2B buyers and CBD Expo Midwest 2021 participants,” commented Ian James, CEO of The Jordre Well, LLC. “The Expo comes as consumers seek greater self-care products, and we look forward to meeting their expectations and demand for excellent tasting plant-based wellness beverages.”

About Coffee Holding Co., Inc.

Founded in 1971, Coffee Holding Co., Inc. (NASDAQ: JVA) is a leading integrated wholesale coffee roaster and dealer in the United States and one of the few coffee companies that offers a broad array of coffee products across the entire spectrum of consumer tastes, preferences and price points. Coffee Holding has been a family-operated business for three generations and has remained profitable through varying cycles in the coffee industry and the economy. The Company’s private label and branded coffee products are sold throughout the United States, Canada and abroad to supermarkets, wholesalers, and individually owned and multi-unit retail customers.

About The Jordre Well, LLC

Based in Columbus, Ohio, The Jordre Well is a functional brand incubator focused on the creation of innovative, sustainably-sourced, CBD-infused beverages for health and wellness conscious consumers. The Jordre Well’s soon-to-be-released brands include its namesake seltzer brand, The Jordre Well, its curated coffee collection, Stephen James, and more. To learn more, visit https://thejordrewell.com/.

Forward-looking statements

Any statements that are not historical facts contained in this release are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including those related to the testing and availability of CBD-infused coffee products. Forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, expectations, anticipations, assumptions, estimates, intentions, and future performance, and involve known and unknown risks, uncertainties and other factors, which may be beyond our control, and which may cause our actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. All statements other than statements of historical fact are statements that could be forward-looking statements. We have based these forward-looking statements upon information available to management as of the date of this release and management’s expectations and projections about certain future events. It is possible that the assumptions made by management for purposes of such statements may not materialize. Such statements may involve risks and uncertainties, including but not limited to those relating to product demand, pricing, market acceptance, hedging activities, the effect of economic conditions, the effect of the COVID-19 pandemic, intellectual property rights, the outcome of competitive products, risks in product development, the results of financing efforts, the ability to complete transactions and other factors discussed from time to time in the Company’s Securities and Exchange Commission filings. The Company undertakes no obligation to update or revise any forward-looking statement for events or circumstances after the date on which such statement is made.

Andrew Gordon
Coffee Holding Co., Inc.
718-832-0800

CHICAGO, April 07, 2021 (GLOBE NEWSWIRE) — TransUnion (NYSE: TRU) announced today its entrance into the U.S. gaming market through its operating subsidiary, TransUnion Gaming Services LLC, with the intention of providing identity, fraud and marketing solutions to operators across several states. TransUnion will build upon its 12-year history in this industry, most notably in the United Kingdom, to expand its footprint to the $119 billion* U.S. gambling market. Subject to all applicable regulatory approvals, TransUnion Gaming Services will support online sports betting, daily fantasy sports, as well as operators and casinos.

TransUnion Gaming Services will help operators throughout the entire player journey, from acquisition to onboarding and verification while providing their players a friction-right experience. Its solutions will address industry fraud, such as bonus abuse, while protecting player accounts and offering reduced login friction.

Such solutions will be provided through TruValidate™, TransUnion’s flagship identity proofing, risk-based authentication and fraud analytics solution suite. TruValidate unites personal and digital data into one of the most comprehensive data identity platforms in the world.

“TransUnion will bring its long international history in the gaming markets to the U.S., where we will leverage our expertise to provide great experiences to both players and businesses,” said Steve Chaouki, President of U.S. Markets at TransUnion. “As trusted stewards of data, consumer privacy and experience quality are always top of mind. We will deliver capabilities and solutions that allow our customers to more seamlessly comply with regulations while delivering high consumer satisfaction.”

As competition increases in the gaming industry, TransUnion Gaming Services also will offer its digital marketing solutions to help operators understand, resolve and optimize their initiatives to better reach players. These digital marketing solutions leverage artificial intelligence (AI) and machine learning to provide data-driven insights, allowing operators to connect insights throughout the audience development and activation process.

“We have plans to rapidly grow our business in the U.S., leveraging years of global expertise in the industry and new solutions that will make us a key contributor in this market,” said Glen Goldstein, TransUnion’s Diversified Markets EVP and President of TransUnion Gaming Services. “Ultimately, our entrance into the U.S. market will afford more trustworthy relationships between operators and their players.”

While TransUnion has been at the forefront of gaming solutions in the U.K. market, helping operators protect players through better data and actionable insights while promoting responsible gaming, it now seeks to capitalize upon that success through TransUnion Gaming Services in the U.S. In the U.K., TransUnion has serviced 84 million transactions for top gaming brands related to identity verification, fraud and responsible gaming.

TransUnion Gaming Services is in the process of applying for multiple state licenses to work with U.S. operators to offer them scale and reduce their third-party costs.

For more information about TransUnion’s gaming business, please click here.

*https://www.prnewswire.com/news-releases/global-gambling-industry-301107436.html

About TransUnion (NYSE: TRU)

TransUnion is a global information and insights company that makes trust possible in the modern economy. We do this by providing a comprehensive picture of each person so they can be reliably and safely represented in the marketplace. As a result, businesses and consumers can transact with confidence and achieve great things. We call this Information for Good.^®

A leading presence in more than 30 countries across five continents, TransUnion provides solutions that help create economic opportunity, great experiences and personal empowerment for hundreds of millions of people.

http://www.transunion.com/business

Contact	Dave Blumberg
	TransUnion
E-mail	[email protected]
Telephone	312-972-6646

 

SALT LAKE CITY, April 07, 2021 (GLOBE NEWSWIRE) — HireVue, the global leader in video interviewing, assessments, chatbot and recruiting automation technology, today released audit results evaluating its application of Industrial/Organizational (IO) Psychology to job candidate selection. Conducted by Landers Workforce Science LLC, the audit concludes:

“In general, HireVue reaches or exceeds industry standards for the creation of high-stakes assessments, and this audit exposed no weaknesses that critically undermine HireVue’s approach.”

At the start of building every assessment, HireVue’s team of IO Psychologists performs a detailed Job Analysis that identifies the competencies required to be successful in a particular role at a particular company. Our team then designs structured interview questions and game-based challenges that allow candidates to demonstrate those competencies. This process gives employers a clear, quantifiable result to assist selection decisions, while minimizing bias by removing decisions traditionally based on gut feeling, which is often subject to conscious and unconscious biases.

Central to the audit findings is the conclusion that the HireVue job analysis process was “of very high quality and rigor in relation to established standards…resulting in the creation of trustworthy content-related validation evidence and subsequent hiring decisions.” Also of note was Dr. Landers’ conclusion about the company’s use of AI and IO Psychology produces results supported by IO Psychology science.

The Audit Procedure

The audit was conducted by distinguished professor and CEO of Landers Workforce Science LLC, Dr. Richard Landers. Dr. Landers spent considerable time interviewing the HireVue science team, and reviewed close to 1000 pages of documentation, with follow-up Q&A, to reach the final version of the audit narrative. The report details HireVue’s methods for evaluating job candidates’ readiness for the job, documenting the reliability and validity of its approach, and conducting testing and mitigation to minimize bias for a protected class or group of job seekers.

“This audit affirms HireVue’s application of IO Psychology to identify qualified candidates based on job-related criteria, not gut instinct,” said Kevin Parker, Chairman and CEO of HireVue. “Third-party audits like these help us identify opportunities for future research and product improvements that have immediate benefit to our customers and their job candidates.”

Future Research and Product Enhancements

At the conclusion of the audit, the science team used the results to identify assessment improvement areas, such as the need for blending structured interviewing, conversational AI, and chatbot technology into an elegant assessment for applicants. The full audit narrative and details about future research and product improvements can be found at http://hirevue.com/resources/hirevue-io-psychology-audit-report.

HireVue’s commitment to defining the transparent and appropriate use of AI and software in hiring is ongoing, and the audit is part of a broader company effort to continually fine tune its assessments with regularly scheduled product updates throughout the year.

More details on our commitment to AI Ethics and the standards that drive our science can be found at www.hirevue.com/why-hirevue/ai-ethics

About HireVue

HireVue is where hiring happens – transforming the way organizations discover, engage, and hire the best talent. Connecting companies and candidates anytime, anywhere, HireVue’s industry leading end-to-end hiring platform features video interviewing, assessments and conversational AI. HireVue has hosted more than 20 million video interviews and 143M chat-based candidate engagements for over 700 pioneering customers around the globe.

HireVue Social Networks
Twitter: www.twitter.com/HireVue
LinkedIn: www.linkedin.com/company/hirevue
Facebook: www.facebook.com/HireVue
YouTube: www.YouTube.com/user/HireVue
Instagram: www.instagram.com/hirevue/

Press Contact
Andrea Judson-Torres
Highwire PR
310-592-6341
[email protected]

 

BOSTON, April 07, 2021 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic diseases of obesity, today announced that David Meeker, M.D., Chair, President and Chief Executive Officer, will participate in a fireside chat at the 20^th Annual Needham & Co. Virtual Healthcare Conference on Wednesday, April 14, 2021 at 11:45 a.m. ET.

A live audio webcast of the presentation will be available under “Events & Presentations” in the Investor Relations section of the Company’s website at www.rhythmtx.com. A replay of the webcast will be available on the Rhythm website for 30 days following each presentation.

About Rhythm Pharmaceuticals

Rhythm is a commercial-stage biopharmaceutical company committed to transforming the treatment paradigm for people living with rare genetic diseases of obesity. The Company’s precision medicine, IMCIVREE™ (setmelanotide), has been approved by the FDA for chronic weight management in adult and pediatric patients 6 years of age and older with obesity due to POMC, PCSK1 or LEPR deficiency confirmed by genetic testing. IMCIVREE is the first-ever FDA approved therapy for these rare genetic diseases of obesity. Rhythm is advancing a broad clinical development program for setmelanotide in other rare genetic diseases of obesity. The Company is leveraging the Rhythm Engine and the largest known obesity DNA database – now with approximately 37,500 sequencing samples – to improve the understanding, diagnosis and care of people living with severe obesity due to certain genetic deficiencies. The company is based in Boston, MA.

IMCIVREE™ (setmelanotide) Indication

IMCIVREE is indicated for chronic weight management in adult and pediatric patients 6 years of age and older with obesity due to proopiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) deficiency. The condition must be confirmed by genetic testing demonstrating variants in POMC, PCSK1, or LEPR genes that are interpreted as pathogenic, likely pathogenic, or of uncertain significance (VUS).

Limitations of Use

IMCIVREE is not indicated for the treatment of patients with the following conditions as IMCIVREE would not be expected to be effective:

• Obesity due to suspected POMC, PCSK1, or LEPR deficiency with POMC, PCSK1, or LEPR variants classified as benign or likely benign;
• Other types of obesity not related to POMC, PCSK1 or LEPR deficiency, including obesity associated with other genetic syndromes and general (polygenic) obesity.

Important Safety Information

WARNINGS AND PRECAUTIONS

Disturbance in Sexual Arousal: Sexual adverse reactions may occur in patients treated with IMCIVREE. Spontaneous penile erections in males and sexual adverse reactions in females occurred in clinical studies with IMCIVREE. Instruct patients who have an erection lasting longer than 4 hours to seek emergency medical attention.

Depression and Suicidal Ideation: Some drugs that target the central nervous system, such as IMCIVREE, may cause depression or suicidal ideation. Monitor patients for new onset or worsening of depression. Consider discontinuing IMCIVREE if patients experience suicidal thoughts or behaviors.

Skin Pigmentation and Darkening of Pre-Existing Nevi: IMCIVREE may cause generalized increased skin pigmentation and darkening of pre-existing nevi due to its pharmacologic effect. This effect is reversible upon discontinuation of the drug. Perform a full body skin examination prior to initiation and periodically during treatment with IMCIVREE to monitor pre-existing and new skin pigmentary lesions.

Risk of Serious Adverse Reactions Due to Benzyl Alcohol Preservative in Neonates and Low Birth Weight Infants: IMCIVREE is not approved for use in neonates or infants.

ADVERSE REACTIONS

• The most common adverse reactions (incidence ≥23%) were injection site reactions, skin hyperpigmentation, nausea, headache, diarrhea, abdominal pain, back pain, fatigue, vomiting, depression, upper respiratory tract infection, and spontaneous penile erection.

USE IN SPECIFIC POPULATIONS

Discontinue IMCIVREE when pregnancy is recognized unless the benefits of therapy outweigh the potential risks to the fetus.

Treatment with IMCIVREE is not recommended for use while breastfeeding.

To report SUSPECTED ADVERSE REACTIONS, contact Rhythm Pharmaceuticals at +1 (833) 789-6337 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

See Full Prescribing Information for IMCIVREE.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding our business strategy and plans and our participation in upcoming events and presentations. Statements using word such as “expect”, “anticipate”, “believe”, “may”, “will” and similar terms are also forward-looking statements. Such statements are subject to numerous risks and uncertainties, including, but not limited to, the impact of our management transition, our ability to enroll patients in clinical trials, the design and outcome of clinical trials, the impact of competition, the ability to achieve or obtain necessary regulatory approvals, risks associated with data analysis and reporting, our liquidity and expenses, the impact of the COVID-19 pandemic on our business and operations, including our preclinical studies, clinical trials and commercialization prospects, and general economic conditions, and the other important factors discussed under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2020 and our other filings with the Securities and Exchange Commission. Except as required by law, we undertake no obligations to make any revisions to the forward-looking statements contained in this release or to update them to reflect events or circumstances occurring after the date of this release, whether as a result of new information, future developments or otherwise.

Corporate Contact:

David Connolly
Head of Investor Relations and Corporate Communications
Rhythm Pharmaceuticals, Inc.
857-264-4280
[email protected]

Investor Contact:

Hannah Deresiewicz
Stern Investor Relations, Inc.
212-362-1200
[email protected]

Media Contact:

Adam Daley
Berry & Company Public Relations
212-253-8881
[email protected]

LAS VEGAS, April 07, 2021 (GLOBE NEWSWIRE) — via InvestorWire – ISW Holdings, Inc. (OTC: ISWH) (“ISW Holdings” or the “Company”), a global brand management holdings company with commercial operations in telehealth and cryptocurrency mining, is thrilled to announce that the Company has signed an agreement (the “Agreement”) with GPL Ventures (“GPL”) to eliminate over $2.4 million in convertible promissory notes.

The Agreement covers all convertible debt held by GPL and represents more than 92% of the Company’s outstanding convertible debt obligations.

“This is a huge step,” commented Alonzo Pierce, president and chairman of ISW Holdings. “We are making good on our anti-dilution pledge announced last year and taking strong action to reduce or completely eliminate toxic debt and dilution risk from the equation for our shareholders. This enormous step prevents millions of shares from coming onto the market. We were able to take this step as a direct result of strong operational performance and a significantly improved outlook ahead.”

The Company notes that all of the outstanding capital obligation to GPL was subject to conversion at a significant discount to the stock’s current trading levels, potentially followed by immediate liquidation by GPL. However, as a result of the Company’s move to eliminate the obligation, no related conversion or liquidation will take place.

The Company continues to move forward with the commitments made in its anti-dilution initiative, as announced in December 2020. Since that announcement, the Company has reduced outstanding shares by nearly 25%, reduced authorized shares by 88% down to 60 million, and eliminated over $3.4 million (or 94%) of outstanding convertible debt.

About ISW Holdings

ISW Holdings, Inc. (ISWH), based in Nevada, is a diversified portfolio company comprised of essential business lines that serve consumer product demands. Our expertise lies in strategic brand development, early growth facilitation, as well as brand identity through our proprietary procurement process. Together, with our partners, we seek to provide a structure that meets large scalability demands, as well as anticipated marketplace needs. We are able to meet these needs through a variety of strategic innovative processes. ISWH is creating and managing brands across a spectrum of disruptive industries. It maneuvers its proprietary companies through critical stages of market development, which includes conceptualization, go-to-market strategies, engineering, product integration, and distribution efficiency. The company has also partnered with a well-known software development and consulting company, Bengala Technologies LLC, which is developing significant enhancements in the supply chain management space; and the partnership has a vitally needed patent now pending.

For more information, visit www.iswholdings.com.

Forward-Looking Statements
This press release may contain forward-looking statements that involve risks and uncertainties. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology including “could,” “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential” and the negative of these terms or other comparable terminology. While these forward-looking statements, and any assumptions upon which they are based, are made in good faith and reflect our current judgment regarding the direction of our business, actual results will almost always vary, sometimes materially, from any estimates, predictions, projections, assumptions or other future performance suggested in this report. Except as required by applicable law, we do not intend to update any of the forward-looking statements so as to conform these statements to actual results. Investors should refer to the risks disclosed in the Company’s reports filed from time to time with OTC Markets (www.otcmarkets.com).

Company Contact:


[email protected]

Public Relations
EDM Media, LLC
https://edm.media

Corporate Communications:

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

WALTHAM, Mass., April 07, 2021 (GLOBE NEWSWIRE) — SeaChange International, Inc. (NASDAQ: SEAC), a leading provider of video delivery platforms, will hold a conference call on Tuesday, April 13, 2021 at 5:00 p.m. Eastern time to discuss its financial results for the fourth quarter and fiscal year ended January 31, 2021. Financial results will be issued in a press release prior to the call.

SeaChange executive management will host the conference call, followed by a question and answer period.

Date: Tuesday, April 13, 2021
Time: 5:00 p.m. Eastern time (2:00 p.m. Pacific time)
U.S. dial-in number: 877-407-8037
International number: 201-689-8037
Meeting Number: 13718351

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Gateway Investor Relations at 949-574-3860.

The conference call will be broadcast live and available for replay here and via the investor relations section of SeaChange’s website.

About SeaChange International, Inc.

SeaChange International (NASDAQ: SEAC) powers hundreds of cloud and on-premises platforms with live TV and video on demand (VOD) for millions of end users worldwide. SeaChange’s end-to-end solution enables operators and content owners to cost-effectively launch a direct-to-consumer video streaming service to manage, curate and monetize their linear and on demand content across all major device platforms such as Smart-TVs, mobile devices, and Set-Top-Boxes. A demonstration of SeaChange’s video streaming platform is available here. For more information on SeaChange, please visit www.seachange.com.

SeaChange Contact:

Matt Glover
Gateway Investor Relations
949-574-3860
[email protected]

BURLINGTON, Mass., April 07, 2021 (GLOBE NEWSWIRE) — Cerence Inc. (NASDAQ: CRNC), AI for a world in motion, today announced that Cerence VP of Product Christophe Couvreur will join leaders from NVIDIA, VMWare, and Akridata to explore edge computing for AI and machine learning workloads in automotive at NVIDIA GTC 21, available on demand on April 12, 2021 at 10:00 am PT.

Couvreur will join Dean Harris, Automotive Business Development, NVIDIA; Manish Harsh, Developer Relations, Autonomous Vehicles, NVIDIA; Alexandra Baleta, Manufacturing and Automotive Industry Director, VMWare; and Sunil Samel, VP, Products, Akridata on this exciting panel. Together, these industry experts will discuss near-edge compute infrastructure for latency-sensitive apps, scale, and cost optimization.

To learn more about NVIDIA GTC 21 and to register, please visit www.nvidia.com/en-us/gtc/.

Cerence Leaders to Join Voice and Automotive Industry Events this Spring

Throughout April and May, Cerence executives will also join leading voice, AI, and automotive industry events as featured experts, including:

• Sanjay Dhawan, CEO, will join the Project Voice Council of 100, a gathering of top CEOs working in conversational AI and voice technology taking place April 13-14, 2021 in Chattanooga, Tenn.
• VP & GM of Apps Nils Lenke and Senior UX Project Manager Vanessa Tobisch will present lessons learned from building conversational AI systems in cars at the International VDI Conference: Future of AI in Automotive on Wednesday, April 28, 2021.
• Cerence will deliver the keynote address at The Voice of the Car Summit, an industry event series exploring the growing intersection of voice technology, conversational AI, and the modern connected car. Sujal Shah, VP & GM, Professional Services, will attend The Voice of the Car Summit East in Detroit, Mich., on May 13, 2021, and Mr. Dhawan will attend the event’s West edition in San Jose, Calif., on May 20, 2021.
• Mr. Lenke will also present on multi-modal concepts for touristic applications in the car at the Automotive HMI, UX & Connectivity Summit on May 18, 2021.

To learn more about Cerence, visit www.cerence.com, and follow the company on LinkedIn and Twitter.

About Cerence Inc.

Cerence (NASDAQ: CRNC) is the global industry leader in creating unique, moving experiences for the mobility world. As an innovation partner to the world’s leading automakers and mobility OEMs, it is helping advance the future of connected mobility through intuitive, powerful interaction between humans and their cars, two-wheelers, and even elevators, connecting consumers’ digital lives to their daily journeys no matter where they are. Cerence’s track record is built on more than 20 years of knowledge and more than 350 million cars shipped with Cerence technology. Whether it’s connected cars, autonomous driving, e-vehicles, or buildings, Cerence is mapping the road ahead. For more information, visit www.cerence.com.

Contact Information

Kate Hickman
Cerence Inc.
Tel: 339-215-4583
Email: [email protected]

FREMONT, Calif., April 07, 2021 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy management technology company and the world’s leading supplier of microinverter-based solar-plus-storage systems, today announced that the Company is now providing 24/7 support for installers and Enphase system owners globally across its phone, online chat, and email communications channels.

Providing around-the-clock support builds on the commitment Enphase has made to delivering the industry’s best customer experience. In recent years, Enphase has introduced online chat support; the Enphase Community platform for direct engagement with other Enphase system owners; Enphase University, an advanced online learning platform; and rapid, remote microinverter activation and returns processing with the Service-on-the-Go tool.

“The expansion to 24/7 customer support illustrates that Enphase understands the importance of backing its installers and being there for customers when the grid is not,” said Joe Dazzio, chief operating officer at Efficient Home Services. “We take providing homeowners with the security of back-up power seriously and always-on support for always-on solar-plus-storage technology is simply the right thing to do for our customers.”

“As Enphase evolves from being the world’s leading supplier of microinverters to becoming the world’s leading home energy management systems provider, having a support organization with 24/7 availability is essential,” said Arthur Souritzidis, CEO of Momentum Solar. “Our customer base continues to grow due to strong demand, and with offerings like 24/7 support from Enphase we can deliver an exceptional customer experience.”

“In just over three years, Enphase has completely changed the game in terms of the kind of customer support installers should expect from a solar and storage technology company,” said Jim Gitas, founder and chief executive officer at Your Energy Solutions. “Home energy security and resilience are vital for all homeowners, and Enphase moving to 24/7 customer support augments our work in ensuring that our customers’ systems are up and running.”

“At Enphase, we are turning our customer-first mantra into meaningful actions,” said Jeff McNeil, chief operating officer at Enphase Energy. “Beyond providing always-on support, we are improving our tools, processes, and systems to deliver an outstanding customer experience. Our worldwide customer service Net Promoter Score (NPS) was above 60% in 2020—10 points higher than the 50% NPS score generally considered excellent for consumer goods and services companies*—signaling we are on the right track.”

Enphase customer support can be reached through the new self-service center at https://enphase.com/en-us/support or by calling (877) 797-4743, or via the chat service icon on the Enphase website. Homeowners can find the Enphase online community at https://community.enphase.com.

*QuestionPro: https://www.questionpro.com/blog/nps-considered-good-net-promoter-score/

About Enphase Energy, Inc.

Enphase Energy, a global energy technology company, delivers smart, easy-to-use solutions that manage solar generation, storage and communication on one intelligent platform. The Company revolutionized the solar industry with its microinverter technology and produces a fully integrated solar-plus-storage solution. Enphase has shipped more than 32 million microinverters, and approximately 1.4 million Enphase-based systems have been deployed in more than 130 countries. For more information, visit www.enphase.com and follow the company on Facebook, LinkedIn and Twitter.

Enphase Energy, Enphase, the E logo, and other trademarks or service names are the trademarks of Enphase Energy, Inc. Other names are for informational purposes and may be trademarks of their respective owners.

Forward-Looking Statements

This press release may contain forward-looking statements, including statements related to the expected capabilities and performance of Enphase Energy’s technology and products; our customer service operations; and the performance by our installation partners. These forward-looking statements are based on Enphase’s current expectations and inherently involve significant risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of certain risks and uncertainties, including those risks described in more detail in Enphase’s most recent Annual Report on Form 10-K and other documents on file with the SEC and available on the SEC’s website at www.sec.gov. Enphase Energy undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events, or changes in its expectations, except as required by law.

Contact: [email protected], (877) 797-4743

VANCOUVER, British Columbia, April 07, 2021 (GLOBE NEWSWIRE) — Myconic Capital Corp. (formerly, Auralite Investments Inc.) (CSE: MEDI) (the “Company” or “Myconic“) is pleased to announce that the Company has appointed Adam Deffett, CFA, as Vice President of Capital Markets & Communications. Mr. Deffett will lead the Company’s internal capital markets initiatives, as well as associated infrastructure and M&A activity with a goal of amplifying its presence across industry and institutional channels.

“Myconic continues to effectively manage its existing investment portfolio, while evaluating accretive clinical consolidation investment opportunities; underpinned by EBITDA and experienced operators,” commented Adam Deffett. “I look forward to working with Myconic’s C-Suite to expand their capital markets strategies and M&A tactics, in accordance with its existing investment policy and in pursuit of providing significant value to our stakeholders.”

Adam Deffett is a senior capital markets professional with over 15 years of experience in the Canadian equity markets. Adam began his career at RBC Capital Markets and has held senior positions in both sales and trading at various Canadian banks and independent dealers, most recently as Managing Director and Head of Institutional Sales at Laurentian Bank. He has extensive experience in capital raising, shareholder communication and capital markets strategy. Adam also has experience in regulated industries, advising several companies in the cannabis sector before joining a publicly listed company as Senior VP, Corporate Development. Adam graduated with a Bachelor of Commerce degree from the University of Calgary and is a CFA Charterholder. 

ABOUT MYCONIC

Myconic Capital Corp is an investment issuer with a diversified portfolio that is focused on emerging companies active in the high-tech, real estate, cannabis, mining and health & wellness sectors.

On behalf of:

MYCONIC CAPITAL CORP.

“Robert Meister“

Robert Meister

CEO and Director

For further information, please contact:

Robert Meister
Tel: 604-351-6647
Or Email: [email protected]
https://myconiccapital.com/

The Canadian Securities Exchange (the “CSE”) has not reviewed and does not accept responsibility for the accuracy or adequacy of this release.

Notice Regarding Forward Looking Information:

This news release contains forward-looking statements including statements regarding any of the Myconic holdings or investments, as well other statements that are not historical facts. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties, both general and specific, that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. These assumptions, risks and uncertainties include, among other things, the state of the economy in general and capital markets in particular, investor interest in the business and future prospects of the Company.

The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities law. Additionally, the Company undertakes no obligation to comment on the expectations of, or statements made, by third parties in respect of the matters discussed above.